Cornerstone Wealth Management LLC increased its position in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 4.3% during the 3rd quarter, Holdings Channel reports. The institutional investor owned 9,013 shares of the biopharmaceutical company’s stock after purchasing an additional 373 shares during the quarter. Cornerstone Wealth Management LLC’s holdings in Gilead Sciences were […]
Savant Capital LLC lessened its holdings in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 0.6% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 26,625 shares of the biopharmaceutical company’s stock after selling 151 shares during the […]
Gilead Sciences, Inc (NASDAQ:GILD) Stock Position Lifted by Avantax Planning Partners Inc theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Gilead Sciences (NASDAQ:GILD – Free Report) had its price objective upped by Barclays from $82.00 to $85.00 in a report issued on Tuesday, Benzinga reports. They currently have an equal weight rating on the biopharmaceutical company’s stock. A number of other equities research analysts have also recently commented on GILD. UBS Group dropped their target […]
MGO One Seven LLC cut its holdings in Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 10.4% during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 6,697 shares of the biopharmaceutical company’s stock after selling 781 shares during the period. MGO […]